Author:
Wilkins Anna,Shahidi Mehdi,Parker Chris,Gunapala Ranga,Thomas Karen,Huddart Robert,Horwich Alan,Dearnaley David
Reference51 articles.
1. A report showing the incidence and mortality of the twenty most common cancers diagnosed in the UK, with analysis by age and sex Cancer Research UK Mortality Statistics 2012
2. Design and end points of clinical trials for patients with progressive prostate cancer and castrate levels of testosterone: recommendations of the Prostate Cancer Clinical Trials Working Group;Scher;J Clin Oncol,2008
3. Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer;Tannock;N Engl J Med,2004
4. Prednisone plus cabazitaxel or mitoxantrone for metastatic castration-resistant prostate cancer progressing after docetaxel treatment: a randomised open-label trial;de Bono;Lancet,2010
5. Overall survival benefit and safety profile of radium-223 chloride, a first-in-class alpha-pharmaceutical: results from a phase III randomized trial (ALSYMPCA) in patients with castration-resistant prostate cancer (CRPC) with bone metastases;Parker;J Clin Oncol,2012
Cited by
25 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献